Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Complete Genomics opens U.S. supply chain to genomic sequencing customers through a new manufacturing facility at its San Jose, Calif. headquarters 2024-05-23 21:00
Vatech Partners with Tygerberg Public Hospital to Improve Dental Care in South Africa 2024-05-23 21:00
Laekna Announces FDA Approval for the Phase III Clinical Trial Protocol of LAE002 (Afuresertib) PLUS LAE001 for the Treatment of Prostate Cancer 2024-05-23 20:42
111, Inc. Announces First Quarter 2024 Unaudited Financial Results 2024-05-23 16:43
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, Presented Preclinical Data on Eye Drops from its Proprietary OPC Platform at ARVO 2024 2024-05-23 08:51
Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies 2024-05-23 07:23
Aiming for New Quality Productivity, Aiding in Reaching the Summit of Global Innovative Pharmaceuticals 2024-05-22 22:38
Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care 2024-05-22 21:00
GV Announces Cooperation with CICC 2024-05-22 20:30
I-Mab to Participate at the Jefferies Global Healthcare Conference 2024-05-22 19:00
Waterdrop Inc. to Report First Quarter 2024 Financial Results on June 5, 2024 2024-05-22 18:00
GCCL Leverages ddPCR to Enhance Gene/cell Therapy Clinical Trial Services 2024-05-22 13:00
Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston's Biotech Hub 2024-05-21 21:00
Ractigen Therapeutics Secures FDA Fast Track Designation for RAG-01, a First-in-Class saRNA Therapy 2024-05-21 20:00
Cali Biosciences Announces Publication of Successful Phase 2 Study Results in Hernia 2024-05-21 17:52
So-Young to Report First Quarter 2024 Financial Results on May 28, 2024 2024-05-21 17:00
NUS scientists discover a novel way of activating muscle cells' natural defences against cancer using magnetic pulses 2024-05-21 16:35
Simcere Phar-maceuticals Presented Six Studies on Sanbexin® at ESOC 2024 2024-05-21 15:52
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance 2024-05-21 15:12
ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance treatment through two years for adults with moderately to severely active Crohn's disease and ulcerative colitis 2024-05-21 12:01
1 32 33 34 35 36 800